Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetic DDI Study of HUC2A-752-A and HUC2A-752-B in Healthy Adults
NCT07784621Phase 1Not yet recruiting
- Sponsor
- Huons
- Start
- Oct 2026
- Primary completion
- Feb 2027
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial in hypertension (HTN) comparing Losartan with Pitavastatin/Ezetimibe (2 arms). Primary endpoints: Area Under the Concentration-Time Curve During a Dosing Interval at Steady State at Day 15 and Maximum Observed Plasma Concentration at Steady State at Day 15. Planned start Oct 2026; status: not yet recruiting.
02
Drugs
losartanpitavastatinezetimibe
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT07784621.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07784621.